Acefurtiamine: Difference between revisions
Created page with "<languages /> <translate> <!--T:1--> {{Short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 477237993 | IUPAC_name = (3''E'')-4-{[(4-Amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-3-[(furan-2-ylcarbonyl)sulfanyl]pent-3-en-1-yl (acetyloxy)acetate | image = Acefurtiamine.svg | width = | drug_name = <!--Clinical data--> | tradename = | licence_EU = <!-- EMEA requires brand name --> | licence_US = <!--..." |
No edit summary |
||
| Line 47: | Line 47: | ||
<!--T:3--> | <!--T:3--> | ||
'''Acefurtiamine''' ([[International Nonproprietary Name|INN]]) is a [[Vitamin B1 analogue|vitamin B<sub>1</sub> analog]] in a manner similar to the [[GABA]]ergic activity of the [[thiamine]] derivative [[clomethiazole]]. | '''Acefurtiamine''' ([[International Nonproprietary Name|INN]]) is a [[Vitamin B1 analogue|vitamin B<sub>1</sub> analog]] in a manner similar to the [[GABA]]ergic activity of the [[thiamine]] derivative [[clomethiazole]]. It functions as an [[analgesic]] agent at sufficient doses. | ||
== Further reading == <!--T:4--> | == Further reading == <!--T:4--> | ||